Market Cap

Trevi Therapeutics, Inc. Market Capitalization:

$724.4 Million

USD as of July 1, 2025

business Trevi Therapeutics, Inc. Company Profile

Trevi Therapeutics, Inc. Main Stock Listing

NASDAQ: TRVI

Market Capitalization History of Trevi Therapeutics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $309.91 B
Vertex Pharmaceuticals Incorporated $117.36 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $59.14 B
Marinomed Biotech AG $58.56 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Trevi Therapeutics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2025 $356.6 M 323.02%
Jan. 1, 2024 $84.3 M -50.12%
Jan. 1, 2023 $169.0 M 268.89%
Jan. 1, 2022 $45.8 M -78.59%
Jan. 1, 2021 $214.0 M -40.16%
Jan. 1, 2020 $357.6 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Trevi Therapeutics, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Trevi Therapeutics, Inc. has the following listings and related stock indices.


Stock: NASDAQ: TRVI

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.